(BOSS) Hugo Boss - Ratings and Ratios
Apparel, Footwear, Accessories, Fragrances, Eyewear
Dividends
| Dividend Yield | 3.95% |
| Yield on Cost 5y | 5.60% |
| Yield CAGR 5y | -13.71% |
| Payout Consistency | 82.9% |
| Payout Ratio | 43.1% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 47.0% |
| Value at Risk 5%th | 69.0% |
| Relative Tail Risk | -10.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.31 |
| Alpha | -14.02 |
| CAGR/Max DD | -0.20 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.704 |
| Beta | 0.196 |
| Beta Downside | 0.263 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.42% |
| Mean DD | 29.13% |
| Median DD | 37.48% |
Description: BOSS Hugo Boss November 08, 2025
Hugo Boss AG (XETRA:BOSS) designs, manufactures and sells apparel, shoes and accessories for men and women under the BOSS and HUGO brands. Its product portfolio also includes licensed lines such as fragrances, eyewear, watches, children’s fashion and cycling gear, which are distributed through a mix of owned stores, shop-in-shops, factory outlets, multi-brand retailers, franchise partners and online channels. The company, founded in 1924 and headquartered in Metzingen, Germany, operates globally across Europe, the Americas and Asia-Pacific.
Key recent metrics (FY 2023) show revenue of €3.3 bn, a 5 % YoY increase driven primarily by a 12 % rise in online sales and a 7 % expansion of its BOSS Business segment in the Greater China market. The EBIT margin improved to 12.4 % from 11.1 % a year earlier, reflecting better cost control and a higher contribution from higher-margin accessories. A material sector driver is the lingering impact of Euro-dollar exchange fluctuations, which historically accounts for roughly 10 % of net income variance for European luxury firms.
For a deeper, data-rich assessment of Hugo Boss’s valuation dynamics, you may find ValueRay’s analytical dashboard a useful next step.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (224.5m TTM) > 0 and > 6% of Revenue (6% = 254.3m TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA 5.22pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.38% (prev 15.28%; Δ 8.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 610.9m > Net Income 224.5m (YES >=105%, WARN >=100%) |
| Net Debt (1.19b) to EBITDA (550.2m) ratio: 2.17 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.97 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (69.0m) change vs 12m ago -0.87% (target <= -2.0% for YES) |
| Gross Margin 61.98% (prev 61.49%; Δ 0.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 119.1% (prev 118.5%; Δ 0.53pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.80 (EBITDA TTM 550.2m / Interest Expense TTM 34.3m) >= 6 (WARN >= 3) |
Altman Z'' 4.28
| (A) 0.28 = (Total Current Assets 1.49b - Total Current Liabilities 502.0m) / Total Assets 3.55b |
| (B) 0.37 = Retained Earnings (Balance) 1.32b / Total Assets 3.55b |
| (C) 0.08 = EBIT TTM 267.8m / Avg Total Assets 3.56b |
| (D) 0.70 = Book Value of Equity 1.47b / Total Liabilities 2.11b |
| Total Rating: 4.28 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 76.44
| 1. Piotroski 6.50pt |
| 2. FCF Yield 14.78% |
| 3. FCF Margin 13.55% |
| 4. Debt/Equity 0.99 |
| 5. Debt/Ebitda 2.17 |
| 6. ROIC - WACC (= 7.40)% |
| 7. RoE 15.79% |
| 8. Rev. Trend 56.30% |
| 9. EPS Trend 1.24% |
What is the price of BOSS shares?
Over the past week, the price has changed by -7.42%, over one month by -5.04%, over three months by -15.81% and over the past year by -3.03%.
Is BOSS a buy, sell or hold?
What are the forecasts/targets for the BOSS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 43.7 | 23.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 36.2 | 2.3% |
BOSS Fundamental Data Overview November 26, 2025
Market Cap EUR = 2.56b (2.56b EUR * 1.0 EUR.EUR)
P/E Trailing = 11.4308
P/E Forward = 9.4073
P/S = 0.6049
P/B = 1.801
P/EG = 1.3344
Beta = 0.883
Revenue TTM = 4.24b EUR
EBIT TTM = 267.8m EUR
EBITDA TTM = 550.2m EUR
Long Term Debt = 276.4m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 397.1m EUR (from shortTermDebt, last fiscal year)
Debt = 1.40b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 1.19b EUR (from netDebt column, last fiscal year)
Enterprise Value = 3.89b EUR (2.56b + Debt 1.40b - CCE 82.0m)
Interest Coverage Ratio = 7.80 (Ebit TTM 267.8m / Interest Expense TTM 34.3m)
FCF Yield = 14.78% (FCF TTM 574.3m / Enterprise Value 3.89b)
FCF Margin = 13.55% (FCF TTM 574.3m / Revenue TTM 4.24b)
Net Margin = 5.30% (Net Income TTM 224.5m / Revenue TTM 4.24b)
Gross Margin = 61.98% ((Revenue TTM 4.24b - Cost of Revenue TTM 1.61b) / Revenue TTM)
Gross Margin QoQ = 61.17% (prev 62.84%)
Tobins Q-Ratio = 1.10 (Enterprise Value 3.89b / Total Assets 3.55b)
Interest Expense / Debt = 0.85% (Interest Expense 12.0m / Debt 1.40b)
Taxrate = 27.71% (23.0m / 83.0m)
NOPAT = 193.6m (EBIT 267.8m * (1 - 27.71%))
Current Ratio = 2.97 (Total Current Assets 1.49b / Total Current Liabilities 502.0m)
Debt / Equity = 0.99 (Debt 1.40b / totalStockholderEquity, last quarter 1.42b)
Debt / EBITDA = 2.17 (Net Debt 1.19b / EBITDA 550.2m)
Debt / FCF = 2.08 (Net Debt 1.19b / FCF TTM 574.3m)
Total Stockholder Equity = 1.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.33% (Net Income 224.5m / Total Assets 3.55b)
RoE = 15.79% (Net Income TTM 224.5m / Total Stockholder Equity 1.42b)
RoCE = 15.77% (EBIT 267.8m / Capital Employed (Equity 1.42b + L.T.Debt 276.4m))
RoIC = 11.97% (NOPAT 193.6m / Invested Capital 1.62b)
WACC = 4.57% (E(2.56b)/V(3.97b) * Re(6.74%) + D(1.40b)/V(3.97b) * Rd(0.85%) * (1-Tc(0.28)))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 81.65 | Cagr: 0.00%
[DCF Debug] Terminal Value 78.12% ; FCFE base≈501.3m ; Y1≈495.6m ; Y5≈514.0m
Fair Price DCF = 132.0 (DCF Value 9.11b / Shares Outstanding 69.0m; 5y FCF grow -1.94% → 3.0% )
EPS Correlation: 1.24 | EPS CAGR: -4.75% | SUE: 0.23 | # QB: 0
Revenue Correlation: 56.30 | Revenue CAGR: 2.39% | SUE: -0.95 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.81 | Chg30d=-0.056 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=3.68 | Chg30d=-0.037 | Revisions Net=-4 | Growth EPS=+10.4% | Growth Revenue=+2.5%